Celcuity

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celcuity and other ETFs, options, and stocks.

About CELC

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. 

CEO
Brian F. Sullivan
CEOBrian F. Sullivan
Employees
87
Employees87
Headquarters
Minneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded
2012
Founded2012
Employees
87
Employees87

CELC Key Statistics

Market cap
3.37B
Market cap3.37B
Price-Earnings ratio
-22.25
Price-Earnings ratio-22.25
Dividend yield
Dividend yield
Average volume
676.83K
Average volume676.83K
High today
$79.47
High today$79.47
Low today
$76.05
Low today$76.05
Open price
$76.05
Open price$76.05
Volume
437.27K
Volume437.27K
52 Week high
$83.00
52 Week high$83.00
52 Week low
$7.58
52 Week low$7.58

Stock Snapshot

With a market cap of 3.37B, Celcuity(CELC) trades at $79.32. The stock has a price-to-earnings ratio of -22.25.

During the trading session on 2025-11-11, Celcuity(CELC) shares reached a daily high of $79.47 and a low of $76.05. At a current price of $79.32, the stock is +4.3% higher than the low and still -0.2% under the high.

Trading volume for Celcuity(CELC) stock has reached 437.27K, versus its average volume of 676.83K.

Over the past 52 weeks, Celcuity(CELC) stock has traded between a high of $83.00 and a low of $7.58.

Over the past 52 weeks, Celcuity(CELC) stock has traded between a high of $83.00 and a low of $7.58.

CELC News

Nasdaq 4h
Commit To Purchase Celcuity At $40, Earn 22.5% Using Options

Investors considering a purchase of Celcuity Inc (Symbol: CELC) shares, but cautious about paying the going market price of $77.31/share, might benefit from con...

Commit To Purchase Celcuity At $40, Earn 22.5% Using Options
Simply Wall St 5d
A Look at Celcuity’s Valuation Following Its Recent 50% Share Price Surge

Celcuity (CELC) shares have climbed over 50% in the past month, sparking fresh questions about what is driving the momentum for this clinical-stage biotech. The...

A Look at Celcuity’s Valuation Following Its Recent 50% Share Price Surge
Investor's Business Daily 5d
Celcuity Eyeing Cancer Treatment Riddle. Stock Flys 534% This Year.

Celcuity (CELC) Chief Executive Brian Sullivan says the biotech company hopes to "solve a 20-year riddle" in cancer treatment. The journey has sent the biotech...

Celcuity Eyeing Cancer Treatment Riddle. Stock Flys 534% This Year.

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CELC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.